Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ranked by Enplaned passengers at RDU from Jan. 1, 2025, through Dec. 31, 2025 Ranked by Value of funding raise Ranked by Patent attorneys in the Triangle Showcase your company news with guaranteed ...

The nomination deadline is approaching. All submissions must be received by 04/03/2026. Submit Nomination Today These 50 companies earned top marks based on employee survey responses. April 03 If your ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...